131 results
Page 3 of 7
8-K
EX-99.1
crav11lqft6wygtkp
26 Jan 21
Other Events
4:14pm
DEFA14A
k3x52jtqyri1wnp4woac
23 Dec 20
Additional proxy soliciting materials
4:52pm
DEFA14A
EX-2.1
ko1llp3slgqc 5bcgtx
21 Dec 20
Additional proxy soliciting materials
9:17pm
8-K
EX-2.1
4jw95umo2q
21 Dec 20
Entry into a Material Definitive Agreement
9:15pm
DEFA14A
jwli4elw j1j
21 Dec 20
Additional proxy soliciting materials
5:23pm
DEFA14A
EX-99.1
hnntx60 p1m
21 Dec 20
Additional proxy soliciting materials
7:10am
8-K
EX-99.1
hnuw2z
21 Dec 20
Regulation FD Disclosure
7:04am
8-K
EX-99.1
zjv2xf9ifmegsw
7 Dec 20
Agios Announces Updated Data from Phase 1 Study of Mitapivat, First-in-Class PKR Activator, in Sickle Cell Disease
4:53pm
8-K
EX-99.1
wt2ddidpa5 vwda53f
1 Dec 20
Other Events
7:46am
8-K
EX-99.1
27h3y32hi y19v
5 Nov 20
Agios Reports Business Highlights and Third Quarter 2020 Financial Results
7:32am
8-K
EX-99.1
o9k851 n2o4p
30 Jul 20
Agios Reports Business Highlights and Second Quarter 2020 Financial Results
7:17am
8-K
EX-99.2
fhndhiw
12 Jun 20
Entry into a Material Definitive Agreement
7:04am
8-K
EX-99.3
q7wf03pyx71o
12 Jun 20
Entry into a Material Definitive Agreement
7:04am
S-3ASR
zlvy0gxwwqu0uzhp1
30 Apr 20
Automatic shelf registration
4:19pm
8-K
EX-99.1
edy2 oylpa
30 Apr 20
Agios Reports First Quarter 2020 Financial Results and Provides Update on Business Operations andCOVID-19 Response
7:19am